Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study
ARP Rheumatology · 2024
DOI: 10.63032/tevi1838 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift ARP Rheumatology, 2024. Verfasst von Jérôme Granel und 6 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Centre Bordeaux Pellegrin Hospital, Bordeaux, France. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Interleukin 1 Receptor Antagonist Protein, Antirheumatic Agents, Anti-Inflammatory Agents, Non-Steroidal.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University Hospital Centre Bordeaux Pellegrin Hospital, Bordeaux, France.
Zitieren
APA
Granel, J., Ravalet, A., Daghistani, A., Clet, J., Richer, O., Bailhache, M., & Pillet, P. (2024). Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study. ARP Rheumatology. https://doi.org/10.63032/tevi1838
Vancouver
Granel J, Ravalet A, Daghistani A, Clet J, Richer O, Bailhache M, et al. Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study. ARP Rheumatology. 2024. doi:10.63032/tevi1838
BibTeX
@article{Granel2024,
author = {Granel, Jérôme and Ravalet, Adeline and Daghistani, Aseel and Clet, Johanna and Richer, Olivier and Bailhache, Marion and Pillet, Pascal},
title = {Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study},
journal = {ARP Rheumatology},
year = {2024},
doi = {10.63032/tevi1838}
}
EUVIMED